Head and Neck cancers (HNC) are a heterogeneous group of upper aero-digestive tract
cancer and account for 931,922 new cases and 467,125 deaths worldwide. About 90% of …

Simple Summary The field of liquid biopsy is rapidly evolving. Techniques that improve
accuracy are constantly being developed, and clinicians increasingly use liquid biopsy as a …

Genetic investigation of tumor heterogeneity and clonal evolution in solid cancers could be
assisted by the analysis of liquid biopsies. However, tumors of various entities might release …

Head and neck squamous cell carcinoma (HNSCC) encompasses a spectrum of
heterogeneous diseases originating in the oral cavity, pharynx, and larynx. Within the United …

Simple Summary Head and neck cancer remains a challenging and deadly disease as it is
often identified in more advanced stages due to limitations in screening and surveillance …

Simple Summary Curative treatment of head and neck squamous cell carcinoma (HNSCC)
is largely dependent on locoregional control of the disease. However, HNSCCs frequently …

There is no useful biomarker to evaluate treatment response and early relapse in head and
neck squamous cell carcinoma (HNSCC). Circulating tumor DNA (ctDNA) is a promising …

In the era of 'precision medicine', liquid biopsies based on cell-free DNA (cfDNA) have
emerged as a promising tool in the oncology field. cfDNA from cancer patients is a mixture of …

Purposes Although clinical and radiological examinations can be used to diagnose oral
cancer, and surgical pathology remains the gold standard, these conventional methods …

Head and neck squamous cell carcinomas (HNSCCs) are a very heterogeneous group of
malignancies arising from the upper aerodigestive tract. They show different clinical …